Summary
The metabolism of chlorpromazine (CPZ), imipramine (IP), and imipramine-N-oxide (IPNO) was studied in microsomal preparations of various rat tissues in vitro and in the isolated perfused liver. A technique for a total hepatectomy in the rat has been developed, allowing estimations of extrahepatic and hepatic drug metabolism in vivo.
CPZ is converted to its sulfoxide and other metabolites in the liver and, to a minor degree, in many extrahepatic organs except brain and skin. Whole blood of several species shows a remarkable sulfoxidizing activity which can be traced to the hemoglobin and is likely to represent a heme catalysis.
IP is metabolized in the liver in vitro and, to a very minor extent, in lung and kidney. Blood, brain and many other extrahepatic tissues do not metabolize this drug in vitro. However, gastro-intestinal contents of rats and humans demethylate IP to Desmethylimipramine (DMI). This is likely to be the reason for a hepatic/ extrahepatic metabolism ratio of 53/47 measured in sham operated and totally hepatectomized rats.
The occurrence of IPNO metabolism in extrahepatic tissues in vitro was confirmed in vivo with hepatectomized rats. The hepatic/extrahepatic ratio is 10/90. The course of IPNO metabolism, compartmental distribution and biliary excretion of the drug and its metabolites was studied in rat liver perfusion experiments. Immediate partial conversion of IPNO to IP and DMI by hemoglobin was confirmed by perfusion experiments without the liver, and liver perfusions with hemoglobin-free perfusates.
Similar content being viewed by others
References
Beckett, A. H., Hewick, D. S.: The N-oxidation of chlorpromazine in vitro-the major metabolic route using rat liver microsomes. J. Pharm. Pharmacol.19, 134 (1967).
Beisenherz, G., Boltze, H. J., Buecher, T., Czok, R., Garbade, K. H., Meyer-Arendt, E., Pfeideler, G.: Diphosphofructose-Aldolase, Phosphoglyceraldehyd-Dehydrogenase, Milchsäure-Dehydrogenase, Glycerophosphat-Dehydrogenase und Pyruvat-Kinase aus Kaninchenmuskulatur in einem Arbeitsgang. Z. Naturforsch.80, 555 (1953).
Bickel, M. H., Weder, H. J., Aebi, H.: Metabolic interconversions between imipramine, its N-oxide, and its desmethyl derivative in rat tissues in vitro. Biochem. biophys. Res. Commun.33, 1012 (1968).
—, Baggiolini, M.: The metabolism of imipramine and its metabolites by rat liver microsomes. Biochem. Pharmacol.15, 1155 (1966).
—, Minder, R.: Metabolism and biliary excretion of the lipophilic drug molecules, imipramine and desmethylimipramine in the rat. I. Experiments in vivo and with isolated perfused livers. Biochem. Pharmacol.19, 2425 (1970).
—, Weder, H. J.: The total fate of a drug: Kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine. Arch. int. Pharmacodyn.173, 433 (1968).
Coccia, P. F., Westerfeld, W. W.: The metabolism of chlorpromazine by liver microsomal enzyme systems. J. Pharmacol. exp. Ther.157, 446 (1967).
Cochin, J., Axelrod, J.: Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalorphine and normorphine. J. Pharmacol. exp. Ther.125, 105 (1959).
Curry, S. H., Marshall, J. H. L.: Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients. Life Sci.7, 9 (1968).
Dingell, J. V., Sulser, F., Gillette, J. R.: Species differences in the metabolism of imipramine and desmethylimipramine. J. Pharmacol. exp. Ther.143, 14 (1964).
Emmerson, J. L., Miya, T. S.: The metabolism and excretion of35S-chlorpromazine by the rat. J. Pharmacol. exp. Ther.137, 148 (1962).
Fishman, V., Goldenberg, H.: Metabolism of chlorpromazine: Organic-extractable fraction from human urine. Proc. Soc. exp. Biol. (N. Y.)104, 99 (1960).
Hahn, M., Massen, O., Nencki, M., Pawlow, J.: Die Eck'sche Fistel zwischen der unteren Hohlvene und der Pfortader und ihre Folgen für den Organismus. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.32, 161 (1892).
Hammer, W. M., Brodie, B. B.: Application of isotope derivative technique to assay of secondary amines: Estimation of desipramine by acetylation with3H-acetic anhydride. J. Pharmacol. exp. Ther.157, 503 (1967).
Himsworth, H. P.: Exclusion of the liver in the rabbit. J. Physiol. (Lond.)91, 413 (1938).
Matsubara, S., Suter, H., Aebi, H.: Fractionation of erythrocyte catalase from normal, hypocatalatic and acatalatic humans. Humangenetik4, 29 (1967).
Nash, T.: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J.55, 416 (1953).
Posner, H. S., Hearst, E., Taylor, W. S., Cosmides, G. J.: Model metabolites of chlorpromazine and promazine: Relative activities in some pharmacological and behavioral tests. J. Pharmacol. exp. Ther.137, 84 (1962).
Robinson, A. E.: Biotransformation in vitro undergone by phenothiazine derivatives in a liver preparation. J. Pharm. Pharmacol.18, 19 (1966).
Salzman, N. P., Brodie, B. B.: Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. J. Pharmacol. exp. Ther.118, 46 (1956).
Scholz, R.: Untersuchungen zur Redoxkompartmentierung bei der hämoglobinfrei perfundierten Rattenleber. In: W. Staib und R. Scholz, eds.: Stoffwechsel der isoliert perfundierten Leber, S. 25. Berlin-Heidelberg-New York: Springer 1968.
Author information
Authors and Affiliations
Additional information
This study was supported by Schweizerischer Nationalfonds zur Förderung der wissenschaftlichen Forschung (grants 4247 and 5258). The authors are indepted to Dr. A. R. Stofer for human autopsy material, to Mr. H. Kaufmann for the preparation of red cell fractions, and to Mr. M. Bachmann and Miss M. Lagcher for technical assistance.
Rights and permissions
About this article
Cite this article
Minder, R., Schnetzer, F. & Bickel, M.H. Hepatic and extrahepatic metabolism of the psychotropic drugs, chlorpromazine, imipramine, and imipramine-N-oxide. Naunyn-Schmiedebergs Arch. Pharmak. 268, 334–347 (1971). https://doi.org/10.1007/BF00997266
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00997266